Cambridge Investment Research Advisors
NYT icon

Cambridge Investment Research Advisors’s New York Times NYT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NYT Stock Details NYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
9,249
+1,401
+18% +$108K ﹤0.01% 2721
2026
Q1 		$657K Buy
+7,848
New +$594K ﹤0.01% 2564

Other funds holding NYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LP
Linonia Partnership New York $5.6B AUM 1.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors's NYT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its New York Times (NYT) stake by 18% in Q2 2026, buying an estimated $108K and bringing the position to 9,249 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Cambridge Investment Research Advisors first reported a position in NYT in Q1 2026 and has held it in 2 quarters since. The position peaked at $657K in Q1 2026. 628 funds tracked by Wall St. Rank hold NYT as of Q2 2026.

  • Cambridge Investment Research Advisors held 9,249 shares of New York Times worth $647K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,401 New York Times shares in Q2 2026, an estimated $108K.
  • New York Times made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2721 holding.
  • Cambridge Investment Research Advisors first reported a position in New York Times in Q1 2026 and has held it in 2 quarters since.
  • Cambridge Investment Research Advisors's New York Times position peaked at $657K in Q1 2026.
  • 628 funds tracked by Wall St. Rank held New York Times as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.